Abstract. In mammalian oocytes, the ubiquitin-proteasome system (UPS) is suggested to play important roles in oocyte meiosis resumption, spindle assembly, polar body emission and pronuclear formation by regulating cyclin B1 degradation. However, little is known about the direct relationship between zygotic gene activation (ZGA) and degradation of maternal proteins. Here, we investigated the role of the UPS in the onset of ZGA in early mouse embryos. First, we found degradation of cyclin B1 protein in fertilized oocytes at 1 hpi by western blot analysis and used these oocytes throughout this study. Subsequently, we determined optimal experimental conditions for transient inhibition of proteasomal activity by specific and reversible proteasomal inhibitor MG132 in the G1 phase of the first cell cycle. Under the selected optimal conditions, we subjected transient MG132-treated embryos to reverse transcription (RT)-PCR analysis of expression of four ZGA genes, i.e., the hsp70.1, MuERV-L, eif-1a and zscan4d genes. As a result, we found that onset of expression of the four examined ZGA genes was delayed in both normally developed 2-cell embryos and arrested 1-cell embryos. Our results indicate that proteasomal degradation of proteins by the UPS plays a pivotal role in the molecular mechanisms of ZGA in early mouse embryos. Key words: Early embryo, MG132, Mouse, Ubiquitin-proteasome system, Zygotic gene activation (J. Reprod. Dev. 56: [655][656][657][658][659][660][661][662][663] 2010) he proteasome is a large protein complex for degradation of most intracellular proteins in eukaryotic cells [1, 2] . For proteasomal degradation, the substrate proteins are required for tagging by ubiquitin. Generally, the ubiquitin-proteasome system (UPS) is involved in a wide variety of biological processes, including DNA repair, apoptosis, immune response, signal transduction, transcription, metabolism, protein quality control and developmental programs [3, 4] .
(J. Reprod. Dev. 56: [655] [656] [657] [658] [659] [660] [661] [662] [663] 2010) he proteasome is a large protein complex for degradation of most intracellular proteins in eukaryotic cells [1, 2] . For proteasomal degradation, the substrate proteins are required for tagging by ubiquitin. Generally, the ubiquitin-proteasome system (UPS) is involved in a wide variety of biological processes, including DNA repair, apoptosis, immune response, signal transduction, transcription, metabolism, protein quality control and developmental programs [3, 4] .
In mammalian oocytes, the UPS is suggested to play important roles in oocyte meiosis resumption, spindle assembly, polar body emission and pronuclear formation by regulating cyclin B1 degradation [5] [6] [7] . Ubiquitin enzyme E1 [8] , E2 [9] and E3 [10] are active during mammalian spermatogenesis, suggesting that the UPS may play roles during spermatogenesis [11] . In fertilization, ubiquitination of the sperm mitochondrial membranes may assist in destruction of paternal mitochondria at fertilization for promoting the maternal inheritance of mitochondrial DNA in mammals [11, 12] .
In mouse embryos, the onset of zygotic gene activation (ZGA) has been shown to occur after fertilization and is a critical event that governs the maternal-to-zygotic transition (MZT) for embryonic development [13] . The correct regulation of the onset of ZGA is an important process for remodeling of an oocyte to a totipotent zygote. Recently, several studies have implicated the UPS in the regulation of transcription [14] [15] [16] [17] . These observations led us to investigate a potential link between the UPS and onset of ZGA in early mouse embryos.
To understand functional roles of the UPS in the minor ZGA in early mouse embryos, we first determined the optimal concentration and optimal treatment time of proteasome inhibitor MG132 in terms of the best efficiency and fewest side effects by using fertilized oocytes at 1 h post-insemination (hpi), which is completion of second meiotic division was confirmed by cyclin B1 degradation and second polar body (2nd PB) emission. Subsequently, in a reverse transcription (RT)-PCR analysis, we observed the onset of gene expression of four ZGA genes that are known to be endogenous markers of ZGA, i.e., the hsp70.1 [18] , MuERV-L [19] , eif-1a [20] and zscan4d [21] genes, in early mouse embryos treated with MG132 under the optimized experimental conditions in our study. These results provide evidence of an involvement of the UPS in the onset of ZGA in early mouse embryos.
Materials and Methods

Animals
All mice (ICR) were purchased form Kiwa Experimental Animals (Wakayama, Japan) and maintained in light-controlled and air-conditioned rooms. All animal procedures conformed to the Guidelines of Kinki University for the Care and Use of Laboratory Animals.
In vitro fertilization and culture
The procedures for in vitro fertilization were essentially those reported previously [22] . In brief, spermatozoa were collected from the cauda epididymis of a male mouse. The sperm suspension was incubated for 1.5 h to allow for capacitation at 37 C under 5% CO2 in air. Oocytes were collected from the excised oviducts of female mice (2-3 months old) that had been superovulated with pregnant mare serum gonadotropin (PMSG; Serotropin, Teikoku Zoki, Tokyo, Japan) followed 48 h later by treatment with human chorionic gonadotropin (hCG; Puberogen, Sankyo, Tokyo, Japan). Cumulus masses were recovered in a pre-equilibrated HTF medium. The sperm suspension was added to the oocytecontaining medium. Morphologically normal fertilized oocytes with a 2nd PB were collected from the sperm suspension 1 h after insemination. The eggs were cultured in KSOM medium [23] at 37 C under 5% CO2 in air. In addition, we only used fertilized oocytes with male and female pronuclei at 6 hpi for further experiments.
Treatment of proteasome inhibitor MG132
Proteasome inhibitor MG132 (carbobenzoxy-L-leucyl-Lleucyl-L-leucinal) was purchased from Sigma-Aldrich (St. Louis, MO, USA). To inhibit the activity of proteasomes in early embryos, embryos were cultured in KSOM medium supplemented with MG132. For the control, the same protocol was used without MG132.
Western blot analysis
The procedures for western blot analysis were essentially the same as those reported previously [22, 24, 25] . In brief, protein extracts were prepared from MII oocytes and fertilized oocytes at 1 hpi, at which time the second polar body (2nd PB) was already extruded from metaphase II oocytes after fertilization. The supernatants (50 cells of each stage) were subjected to SDS polyacrylamide gel electrophoresis. The proteins were resolved in 10% running gels and electrophoretically transferred to PVDF membranes (GE Healthcare, Little Chalfont, UK). The membranes were incubated in block ace (Dainippon-Pharm, Osaka, Japan) for 1 h at room temperature. They were then washed with phosphate buffered saline containing 0.2% Tween 20 (PBST) and incubated overnight at 4 C with anti-cyclin B1 antibody (1:500, Santa Cruz Biotechnology, Heidelberg, Germany; sc-752). The blots were washed in PBST, incubated with donkey anti-rabbit Ig-HRP conjugate (1:7,500; Amersham, Chicago, IL, USA) for 1 h at room temperature, washed with PBST and developed by enhanced chemiluminescence (ECL, Amersham). Actin (1:7,500, Santa Cruz Biotechnology; sc-1616) was used as a loading control.
RT-PCR analysis
The procedures for reverse transcription (RT)-PCR analysis were essentially the same as those reported previously [24] . In brief, in RT-PCR analysis, mRNA was isolated from 20 embryos in each experimental group. Then, the mRNA was supplemented with Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) to synthesize first-strand cDNA. RT-PCR was carried out using each specific primer set for hsp70.1, MuERV-L, eif-1a and zscan4d ( Table 1 ). The reaction parameters were one cycle at 94 C for 5 min and 35 cycles at 94 C for 30 sec, 60 C for 30 sec and 72 C for 30 sec. The RT-PCR products were electrophoresed on 2% agarose gels. For the positive control, glyceraldehyde-3-phosphate dehydrogenase (G3PDH) cDNA was amplified using sense (5'-ACCACAGTCCATGCCATCAC-3') and antisense (5'-TCCACCACCCTGTTGCTGTA-3') primers. Three independent experiments were performed for each.
Results
Confirmation of cyclin B1 degradation in fertilized oocytes by western blot analysis
Proteasomal degradation of cyclin B1 is absolutely essential for the decrease in maturation promoting factor (MPF) and completion of second meiotic division [5, 6, 26] . In this study, we needed to use embryos at exit from second meiosis followed by cyclin B1 degradation in order to eliminate the effect of the UPS on meiotic cell cycle progression and investigate the involvement of the UPS in the onset of ZGA in early mouse embryos. In this regard, we compared the cyclin B1 protein level between ovulated oocytes at 0 hpi and fertilized oocytes with a 2nd PB at 1 hpi by western blot analysis using anti-cyclin B1 antibody. As a result, we could detect no amount of cyclin B1 protein in fertilized oocyte at 1 hpi (Fig.  1A) , indicating that second meiotic division was completed. So, we used fertilized oocytes at 1 hpi throughout this study. (bp) 
Determination of the minimum dose that inhibits the proteasomal activity in early mouse embryos
Completion of first mitotic division is known to depend on proteasomal degradation of cyclin B1 [27] . To determine the minimum dose of MG132 that is most efficient in inhibition of first mitotic division, fertilized oocytes at 1 hpi were treated with various concentrations of MG132 (0, 1, 5, 10 and 20 μM) for 95 h (from 1 to 96 hpi; Fig. 1B) . As a result, MG132 inhibited the first mitotic division in a dose-dependent manner (Fig. 1C) . The rate of development to the 2-cell stage in 1 μM MG132-treated embryos was 73 ± 4%, whereas all of the 5, 10 and 20 μM MG132-treated embryos were arrested at the 1-cell stage. Arrested 1-cell embryos exhibited nuclei with a concave-like shape in the pronuclei (Fig.   1D ). Overall, we decided to use 5 μM MG132 as the minimum dose that inhibits the proteasomal activity in early mouse embryos.
Determination of the optimal transient treatment time for both inhibition of proteasomal activity and progression through first mitotic division in early mouse embryos
MG132 is a reversible inhibitor of proteasome proteolytic activity [28] . The reversible effect of MG132 is also shown in rat 1-cell embryos [27] . To determine an optimal transient treatment time both for inhibition of proteasomal activity and progression of first mitotic division in early mouse embryos, fertilized oocytes at 1 hpi were treated with 5 μM MG132 for 0 h (control), 2 h (from 1 to 3 hpi), 5 h (from 1 to 6 hpi), 8 h (from 1 to 9 hpi), 11 h (from 1 to 12 hpi) and 107 h (from 1 to 108 hpi) and then transferred and cultured in KSOM medium for 107, 105, 102, 99, 96 and 0 h, respectively ( Fig. 2A) . As a result, the rates of development to the 2-cell stage at 24 hpi, 4-cell stage at 48 hpi, 8-cell stage to morulae at 72 hpi, blastocysts at 96 hpi and blastocysts and hatched blastocysts at 108 hpi were gradually decreased in accordance with treatment time of MG132 in a time-dependent manner (Fig. 2B) . The rates of development to the 2-cell stage, at which time minor ZGA already occurs, in embryos treated with MG132 for 5 h (41 ± 4%), 8 h (21 ± 3%) and 11 h (3 ± 2%) were significantly lower than that in MG132-free embryos (100%; P<0.05). Moreover, the rates of development to the 4-cell stage, at which time major ZGA already occurs, in embryos treated with MG132 for 5 h (55 ± 4%), 8 h (26 ± 4%) and 11 h (12 ± 1%) were significantly lower than that in MG132-free embryos (96 ± 1%; P<0.05). From these results, we temporarily concluded that 5 h or 8 h was the optimal transient time for both inhibition of proteasomal activity and progression through first mitotic division in fertilized oocytes. Generally, early mouse embryos are estimated to be in the G2 phase by 9 hpi [29] . Minor ZGA occurs during the late S/G2 phase of the first cell cycle in early mouse embryos [30, 31] . Consistent with these observations, we could not detect the onset of minor ZGA in early mouse embryos by 9 hpi in previous reports [32, 33] . These considerations led us to choose treatment for 8 h (from 1 to 9 hpi) with MG132 as the optimal transient treatment time in terms of having the best efficiency and fewest side effects in the following experiments.
In these experiments, when MG132-treated embryos were cultured in KSOM medium beyond 108 hpi, the rates of development to blastocysts in embryos treated with MG132 for 8 (59 ± 1%) and 11 h (29 ± 4%) were significantly lower than that in MG132-free embryos (89 ± 1%; P<0.05), while the rates of development to blastocysts in embryos treated with MG132 for 2 (74 ± 1%) and 5 h (75 ± 2%) were nearly the same as that in MG132-free embryos (89 ± 1%; Fig. 2C ). This result suggests that transient inhibition of proteasomal activity by MG132 during the G1 and early S phases (from 1 to 11 hpi) of the first cell cycle can only delay development of 1-cell embryos to blastocysts, but cannot completely prevent their development. In fact, the preimplantation development of the 1-cell embryos treated with MG132 during the G1 phase of the first cell cycle was morphologically normal (Fig. 2D) , although we observed nuclei with a concave-like shape in the pronuclei of 1-cell embryos at the pronuclear stage (Fig. 2E) . This structure is also observed in embryos treated with more than 5 μM of MG132 (Fig.   1D ). This shape of nucleoli seems to be similar to unique structures termed dark nucleolar caps surrounding central bodies, which appear to be pressed onto the surface of the nucleolar body [34] .
Evaluation of the optimal experimental conditions for investigating the role of UPS in the onset of ZGA
To evaluate the optimal experimental conditions to understand the role of UPS in the onset of ZGA, fertilized oocytes at 1 hpi were treated with various concentrations of MG132 (0, 1, 5, 10 and 20 μM) for 8 h (from 1 to 9 hpi), as the optimal transient treatment time selected in our experiment, and then transferred and cultured in KSOM medium for 87 h (from 9 to 96 hpi). As shown in Table  2 , the rates of development of the MG132-treated embryos to the 2-cell stage at 24 hpi and blastocysts at 96 hpi were 1% and 0% in both the 10-and 20-μM MG132-treated groups, respectively, whereas the 5-μM MG132-treated embryos could develop to the 2-cell stage (19%) and blastocysts (10%). Finally, we concluded that the optimal experimental conditions for transient inhibition of proteasomal activity by MG132 in the G1 phase of the first cell cycle were 5 μM of MG132 for a treatment time of 8 h (from 1 to 9 hpi) in the case of using fertilized oocytes at 1 hpi.
Investigation of the involvement of the UPS in the onset of ZGA in early mouse embryos
To investigate the involvement of the UPS in the onset of ZGA in early mouse embryos under the selected optimal experimental conditions, that is, 5 μM of MG132 for a transient treatment time of 8 h (from 1 to 9 hpi), we examined the onset of gene expression of four ZGA genes, i.e., the hsp70.1, MuERV-L, eif-1a and zscan4d genes, by RT-PCR analysis. As shown in Fig. 3A , expression of the hsp70.1 gene in arrested 1-cell embryos treated with MG132 was delayed until at least 21 h after the time of onset of gene expression, which was observed at 15 hpi in the MG132-free 1-cell embryos. When the proteasomal activity was inhibited by 5 μM of MG132 for 8 h (from 1 to 9 hpi), expression of the hsp70.1 gene was detected at 24 hpi in normally developed 2-cell embryos and arrested 1-cell embryos (Fig. 3A) . Furthermore, expression of the MuERV-L, eif-1a, and zscan4d genes in arrested 1-cell embryos treated with MG132 was delayed until at least 12, 21 and 15 h after the time of onset of gene expression, which was observed at 9, 15 and 9 hpi in MG132-free 1-cell embryos, respectively (Fig. 3B-D) .
When the proteasomal activity was inhibited by 5 μM of MG132 : treated with MG132 (Control; n=100). : treated with MG132 for 2 h (from 1 to 3 hpi; n=100). : treated with MG132 for 5 h (from 1 to 6 hpi; n=100).
: treated with MG132 for 8 h (from 1 to 9 hpi; n=100). : treated with MG132 for 11 h (from 1 to 12 hpi; n=100).
for 8 h (from 1 to 9 hpi), expression of the MuERV-L, eif-1a and zscan4d genes was detected at 24 hpi in normally developed 2-cell embryos and arrested 1-cell embryos (Fig. 3B-D) . Collectively, these results suggest that the transient inhibition of proteasomal activity by MG132 during the G1 phase of the first cell cycle induces the delay of onset of minor ZGA in early mouse embryos, whereas the onset of minor ZGA in arrested 1-cell embryos is greatly delayed by the subsequent inhibition of proteasomal activity by MG132 throughout the first cell cycle after 1 hpi.
Discussion
The maternal-to-zygotic transition (MZT) is the first major developmental transition that occurs following fertilization [13, 35] . The transition includes degradation of many maternal mRNAs and proteins and initiation of zygotic transcription, resulting in a dramatic reprogramming of gene expression that is responsible for the normal development of preimplantation embryos. ZGA is initially directed by maternally inherited proteins and transcripts, and most maternal transcripts are replaced by new products of zygotic transcription. However, little is known about the direct relationship between ZGA and degradation of maternal proteins. Here, under the optimal conditions both for inhibition of the proteasomal activity and progression of first mitotic division, transient MG132-treated embryos were subjected to RT-PCR analysis of ZGA gene expression. This is the first report to demonstrate direct experimental evidence for the involvement of protein degradation by the UPS in the onset of ZGA in early mouse embryos.
As shown in Fig. 1 , we found degradation of cyclin B1 protein in fertilized oocytes at 1 hpi by western blot analysis and observed pronuclear formation in the 1-cell embryos treated with MG132 after 1 hpi. After oocyte activation is induced by sperm in mammlas, cyclin B1 is quickly degraded by proteasomal activity, which is the prerequisite for the metaphase-to-anaphase transition [36, 37] . Furthermore, when oocytes are treated with MG132 soon after sperm entry, pronuclear formation occurs [38] . Taken together, these results indicate that proteasomal degradation by the UPS occurs very fast after sperm entry and that once this event happens, fertilization events are not affected by the inhibition of proteasomal activity.
In this study, exposure of embryos to 5 μM of MG132 during the first cell cycle completely prevented the first mitotic division (Fig.   1 ), while transient exposure with 5 μM of MG132 in the G1 phase of the first cell cycle delayed development of early mouse embryos in a treatment time-dependent manner (Fig. 2) . In addition, we found that transient exposure to high concentrations of MG132 (10 and 20 μM) in the G1 phase of first cell cycle prevented first mitotic division (Table 2 ). These observations could be explained by the cell cycle-dependent inhibitory effect of MG132 on the development of early mouse embryos. Indeed, in HeLa cells, transient treatment of S phase cells with MG132 results in overreplication of DNA, indicating that proteasomal activity is required for the normal progression of DNA replication in the S phase of the cell cycle [39] . Thus, our results suggests that the possible substrate for proteasomal degradation by the UPS in the G1 phase of the first cell cycle is different from those in the G2/M phase of the first cell cycle, such as cyclin B1.
Subcellular localization of proteasomes and ubiquitinated proteins in early mouse embryos has been reported [5, 40] . The 20S proteasome selectively localizes to the nuclei of 1-to 16-cell embryos [40] , and ubiquitinated proteins also mainly accumulate in the nucleus of 1-to 4-cell embryos [5] . These results suggest that the nuclear localization of 20S proteasomes and ubiquitinated proteins is vital for the function of the UPS in early mouse embryos. Indeed, proteasomes accumulate in euchromatin areas and nucleoli besides peripheral and perinucleolar heterochromatin in MG132-treated culture cells [41] . As shown in Fig. 2E , we observed nuclei with a concave-like shape in the pronuclei of 1-cell embryos transiently treated with MG132 in the G1 phase of the first cell cycle, which may be similar to the unique structures termed as nucleolar caps. Interestingly, formation of nucleolar caps is a normal cellular process associated with transcriptional shut down and druginduced transcriptional arrest [34] . These results allow us to speculate that proteasomes may be related to transcriptional regulation. Further study of the direct involvement of the UPS in nucleolar function in early mouse embryos is needed.
In this study, our results indicate that minor ZGA is delayed by inhibition of proteasomal activity in early mouse embryos, regardless of whether normally developed 2-cell embryos resulted from transient exposure of MG132 in the G1 phase of the first cell cycle or arrested 1-cell embryos resulted from sequent exposure of MG132 throughout the first cell cycle after 1 hpi (Fig. 3) . Recently, the involvement of the UPS in chromatin remodeling and regulating of gene expression has been reported [42] [43] [44] [45] . Ubiquitination of histone H2B directs methylation of histone H3 at lysine residues 4 (K4) and 79 (K79), suggesting that this modification is Significantly different from the control (P< 0.05). * Treated with MG132 from 1 to 9 hpi. ** Treated without MG132 from 9 to 96 hpi.
associated with active chromatin [42, 43] . Stable recruitment of RNA polymerase II (RNAPII) complex to the promoter region and reinitiation of transcription also require the proteolytic function of the proteasomes [44] . Furthermore, the proteolytic activity of proteasomes is necessary for accurate transcription termination. Proteasomes are also involved in clearing the stalled RNAPII and regulating the termination step [45] . However, much work is needed to investigate the role of the UPS in chromatin remodeling and regulation of gene expression in early mouse embryos. In the mouse, the phenomenon of the onset of ZGA being governed by a time-dependent mechanism has been referred to as a zygotic clock, which is set up at fertilization [46, 47] . However, the molecular mechanisms governing the "zygotic clock" are not well known. In historical reports, zygotic transcription occurs on schedule in arrested 1-cell embryos treated with cleavage-blocking drugs such as cytochalasin D [48] or in 1-cell embryos arrested at S phase treated with aphidicolin [46] , while 1-cell embryos treated with the RNA synthesis inhibitor α-amanitin normally cleave to the 2-cell stage [49] . In our study, we found that the onset of ZGA was delayed in normally developed 2-cell embryos, whose proteasomal activity was transiently inhibited at the G1 phase of the first cell cycle. This observation suggests that proteasomal degradation of maternal proteins during specific time windows after fertilization provides a framework for setting up the zygotic clock. To our knowledge, this is the first demonstration of the requirement of time-dependent proteasomal degradation in controlling the time of the onset of ZGA in early mouse embryos.
In conclusion, our study demonstrates that proteasomal degradation of proteins by the UPS plays a pivotal role in the molecular mechanisms of ZGA in early mouse embryos. The UPS is implicated in the extensive proteolysis during MZT [50] . However, the mechanisms underlying the structure and functions of the UPS at the MZT are not well known. Further studies of the structure and function of proteasomes in early mouse embryos will offer novel insight into understanding the remodeling of an oocyte to a totipotent zygote during the MZT.
